Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial Article

ESI Most Cited Paper Industry Collaboration International Collaboration

cited authors

  • Thatcher, Nick; Hirsch, Fred R.; Luft, Alexander V.; Szczesna, Aleksandro; Ciuleanu, Tudor E.; Dediu, Mircea; Ramlau, Rodryg; Galiulin, Rinat K.; Balint, Beatrix; Losonczy, Gyoergy; Kazarnowicz, Andrzej; Park, Keunchil; Schumann, Christian; Reck, Martin; Depenbrock, Henrik; Nanda, Shivani; Letunic, Anamarija Kruljac; Kurek, Raffacl; Paz-Ares, Luis; Socinskf, Mark A.; SQUIRE Investigators

authors

Publication Date

  • July 1, 2015

webpage

published in

category

start page

  • 763

end page

  • 774

volume

  • 16

issue

  • 7